BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30439710)

  • 1. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Shargian-Alon L; Raanani P; Rozovski U; Siegal T; Yust-Katz S; Yeshurun M
    Acta Haematol; 2019; 141(1):19-22. PubMed ID: 30439710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V; Marques A; Ulla M; Ruivard M; Durif F
    Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar Ataxia.
    Jones LA; Baber W; Wardle M; Robertson NP; Morris HR; Church A; Llewelyn JG; Peall KJ
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31646058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible Chronic Graft-versus-host Disease in the Central Nervous System Manifesting as Cerebellar Ataxia after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
    Takahashi K; Katayama T; Ichikawa T; Matsuoka S; Kakinoki Y; Yoneda M; Kimura A; Koyama S; Yahara O
    Intern Med; 2023 Mar; 62(5):779-786. PubMed ID: 35945030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Pirotte M; Forte F; Lutteri L; Willems E; Duran U; Belle L; Baron F; Beguin Y; Maquet P; Bodart O; Servais S
    J Neuroimmunol; 2018 Oct; 323():115-118. PubMed ID: 30189384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
    Aguiar TS; Fragoso A; Albuquerque CR; Teixeira PF; Souza MV; Zajdenverg L; Alves-Leon SV; Rodacki M; Lima MA
    Arq Neuropsiquiatr; 2017 Mar; 75(3):142-146. PubMed ID: 28355320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of anti-gliadin-antibody-positive cerebellar ataxia effectively treated with intravenous immunoglobulin in which voxel-based morphometry and FineSRT were diagnostically useful].
    Nanri K; Otsuka T; Takeguchi M; Taguchi T; Ishiko T; Mitoma H; Koizumi K
    Rinsho Shinkeigaku; 2009 Jan; 49(1):37-42. PubMed ID: 19227895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
    Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
    Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.
    Khaddour K; Musiek A; Cornelius LA; Dehdashti F; Westervelt P; Fields R; Ansstas G
    J Immunother Cancer; 2019 Dec; 7(1):338. PubMed ID: 31801591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
    Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
    Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma.
    Epperla N; Ahn KW; Ahmed S; Jagasia M; DiGilio A; Devine SM; Jaglowski S; Kennedy V; Rezvani AR; Smith SM; Sureda A; Fenske TS; Kharfan-Dabaja MA; Armand P; Hamadani M
    J Hematol Oncol; 2017 Jun; 10(1):117. PubMed ID: 28606176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
    Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
    Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
    Kataria R; Fernandes S; Lebastchi J; Bravo CA; Sena KN
    Conn Med; 2017 Mar; 81(3):161-164. PubMed ID: 29772159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
    J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
    Petrijan T; Menih M
    Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.
    Awad A; Stüve O; Mayo M; Alkawadri R; Estephan B
    Case Rep Neurol Med; 2011; 2011():975152. PubMed ID: 22937348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.